Angus Kinkade
Overview
Explore the profile of Angus Kinkade including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stukas S, Goshua G, Kinkade A, Grey R, Mah G, Biggs C, et al.
Lancet Reg Health Am
. 2022 Mar;
11:100228.
PMID: 35345649
Background: Interleukin-6 inhibitors reduce mortality in severe COVID-19. British Columbia began using tocilizumab 8 mg/kg (maximum 800 mg) in January 2021 in critically ill patients with COVID-19, but due to...
2.
Tung E, Yu S, Shah K, Kinkade A, Tejani A
J Eval Clin Pract
. 2019 Jul;
26(1):18-25.
PMID: 31282101
Rationale, Aims, And Objectives: The majority of hospitalized nonsurgical medical patients receive pharmacological prophylaxis for venous thromboembolism (VTE), and reassessment of changes in thrombosis and bleeding risk factors during hospital...
3.
Hong J, Tung A, Kinkade A, Tejani A
J Clin Epidemiol
. 2018 Dec;
108:144-146.
PMID: 30529004
No abstract available.
4.
Chan A, Liang L, Tung A, Kinkade A, Tejani A
Can J Hosp Pharm
. 2018 Nov;
71(5):295-301.
PMID: 30401995
Background: The use of proton pump inhibitors (PPIs) may cause significant harm to patients in the residential care setting, as these patients are often frail with multiple morbidities. The extent...
5.
Chang E, Kinkade A, Tung A, Tejani A
Can J Hosp Pharm
. 2017 May;
70(2):133-137.
PMID: 28487580
No abstract available.
6.
Jun J, Kinkade A, Tung A, Tejani A
Can J Hosp Pharm
. 2017 May;
70(2):113-119.
PMID: 28487578
Background: Finasteride and dutasteride are competitive inhibitors of 5α-reductase enzymes and are commonly used to treat symptomatic benign prostatic hyperplasia (BPH). Objective: To compare the efficacy and safety of finasteride...
7.
Tam T, Wu M, Masson S, Tsang M, Stabler S, Kinkade A, et al.
Cochrane Database Syst Rev
. 2017 Mar;
2:CD008996.
PMID: 28245343
Background: Eplerenone is an aldosterone receptor blocker that is chemically derived from spironolactone. In Canada, it is indicated for use as adjunctive therapy to reduce mortality for heart failure patients...
8.
Mok M, Kinkade A, Tung A, Tejani A
Can J Hosp Pharm
. 2016 Sep;
69(4):301-5.
PMID: 27621490
No abstract available.
9.
Janssen J, Kinkade A, Man D
Can J Hosp Pharm
. 2015 Sep;
68(4):327-31.
PMID: 26327707
No abstract available.